Clinical Trial Update: Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)

View source ↗

Summary

This clinical trial update describes an ongoing study on the natural history, pathogenesis, and outcomes of autoinflammatory diseases including NOMID/CAPS, DIRA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Still Disease
• Atypical Neutrophilic Dermatosis with Lipodystrophy
• Deficiency of Interleukin-1 Receptor Antagonist
• Neonatal-onset Multisystem Inflammatory Disease
• Nlrc4-related Macrophage Activation Syndrome
• Sting-associated Vasculopathy with Onset in Infancy
• Systemic Juvenile Idiopathic Arthritis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: NOMID, DIRA | Status: RECRUITING